Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
PS-1145 is an IκB kinase β (IKKβ) inhibitor (IC50 = 88 nM).1 It selectively inhibits IKKβ over a panel of 14 kinases (IC50s = >100 nM for all). PS-1145 also inhibits the IKK complex (IC50 = 100 nM).2 It inhibits the proliferation of MM.1S, U266, and RPMI-8226 myeloma cells when used at concentrations ranging from 1.5 to 50 µM. PS-1145 inhibits TNF-α-induced activation of NF-κB in MM.1S cells in a concentration-dependent manner. It inhibits RANKL-induced differentiation of RAW 264.7 cells into osteoclasts when used at concentrations of 5 and 10 µM.3 PS-1145 (10 µM) inhibits RANKL-induced phosphorylation of IκBα, ERK, and JNK in RAW 264.7 cells.
WARNING This product is not for human or veterinary use.
1. NF-
2. Novel IKK inhibitors: β-
3. Nasturtium officinale extract suppresses osteoclastogenesis in RAW 264 cells by inhibiting IκB-